References
Nagashima T, Minota S (2010) Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Clin Rheumatol 29:819–820
Martínez-Cordero E, León DE, Ortega LA (2001) Association of polymyositis with rheumatoid arthritis. Rheumatol Int 20:119–23
Nagashima T, Sato H, Minota S (2009) Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies. J Rheumatol 36:2133–2143
Sattar MA, Al-Sughyer AA, Siboo R (1988) Coexistence of rheumatoid arthritis, ankylosing spondylitis and dermatomyositis in a patient with diabetes mellitus and the associated linked HLA antigens. Br J Rheumatol 27:146–149.
Ginn LR, Lin JP, Plotz PH, Bale SJ, Wilder RL, Mbauya A, Miller FW (1998) Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 41:400–405
Brunasso AM, Scocco GL, Massone C (2010) Dermatomyositis during adalimumab therapy for rheumatoid arthritis. J Rheumatol 37:1549–1550
Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259
Kiltz U, Fendler C, Braun J (2008) Neuromuscular involvement in rheumatic patients treated with anti-tumor necrosis factor therapy–three examples. J Rheumatol 35:2074–2076
Ishikawa Y, Yukawa N, Ohmura K, Hosono Y, Imura Y, Kawabata D et al (2010) Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol 29:563–566
Harald AH, Bernard Z (2006) Evolution of dermatomyositis during therapy with a tumor necrosis factor α inhibitor. Arthritis Rheum 55:982–984
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunasso, A.M., Massone, C. Is dermatomyositis in patients with rheumatoid arthritis induced by anti-TNF-α therapy?. Clin Rheumatol 30, 439–440 (2011). https://doi.org/10.1007/s10067-010-1661-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1661-6